Canakinumab treatment in patients with active recurrent or chronic TNF-receptor associated syndrome (TRAPS): Efficacy and safety results from a proof of concept study

H. Lachmann, M. Cattalini, L. Obici, R. Barcellona, A. Speziale, Y. Joubert, G. Junge, M. Gattorno

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Article numberO59
JournalPediatric Rheumatology
Issue number1
Publication statusPublished - Sep 28 2015

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Pediatrics, Perinatology, and Child Health

Cite this